Digital Health and Regulatory Science
Digital health tools like sensors and software, combined with emerging methods to exploit real world data, can help develop new therapeutics, diagnose and treat disease, and enhance healthcare delivery. The development and use of these emerging tools and data involves rapidly evolving regulatory science considerations to ensure these products are safe and effective.
The UR CTSI Digital Health and Regulatory Science Core can help your studies utilize digital health approaches and offers funding for innovative digital health research. The core also continues to establish a range of partnerships with regional technology development organizations to help connect and support researchers who are developing and using digital health tools, methods and data.
Consultations and Support
Are you developing a new digital health tool or integrating one into your research? Need help formulating your design or selecting the appropriate tool or digital health data? Get your digital health methods questions answered by relevant experts at the UR CTSI Research Methods Forum. (Please note your focus on Digital Health when making a request.)
Request to present at the Forum.
Leveraging expertise across the University of Rochester, the UR CTSI Digital Health and Regulatory Science Core offers Digital Health Seedling awards. This nimble pilot award program is designed to promote innovative, high-risk research that advances the development, approval, adoption and use of innovative digital health tools, methods and approaches.
Learn about the Digital Health Seedling Award.
To speed the translation of digital health technologies and approaches, we help facilitate partnerships between researchers at the University of Rochester and regional technology development organizations, such as NextCorps, Excell Partners and other organizations that provide expertise, services, training and funding to digital health entrepreneurs.
- UR Ventures protects, develops, and commercializes the intellectual property arising from research at the University of Rochester.
- I-Corps Program (including new Digital Health Short Course) helps researchers combine their technical and scientific knowledge with an entrepreneurial mindset, with the goal of discovering new technologies that can be developed for market.
- The UR CTSI and Ain Center for Entrepreneurship and Innovation are hosting a free, virtual I-Corps@NCATS Regional Short Course, in the fall of 2022 for teams of faculty, postdocs and students who have biomedical innovations or ideas they want to translate from the lab to clinical practice.
- NextCorps provides a suite of services, including technology commercialization for very-early-stage opportunities and business incubation for high-growth-potential startups.
- Excell Partners venture capital fund that invests in high-tech, high-growth startups in New York State focused on Upstate NY.
Partners and Resources
There are a broad range of internal and external resources available for researchers interested in developing or utilizing digital tools, methods or data.
Digital Health Resource Library
Finding up-to-date, trustworthy information on digital health can be difficult. That is why the UR CTSI, the Center for Health and Technology at URMC and the Digital Medicine Society partnered to create a crowdsourced library of digital health resources that the community has found to be the most valuable and useful.
Check out the Digital Health Resource Library.
For information on the annual University of Rochester Digital Health Retreat and other events and opportunities for collaborations, please contact Jean-Philippe.Couderc@heart.rochester.edu .
More About the Core
The UR CTSI Digital Health and Regulatory Science Core aims to advance, disseminate and integrate regulatory science knowledge and innovations in digital health to enhance training, translational research and healthcare. Building on core strengths from across the University of Rochester and the region, the core will focus on national and local initiatives that address key translational barriers at the nexus of digital health, regulatory science and personalized medicine.
Jean-Phillippe Couderc, Ph.D., M.B.A.
Karen Grabowski, Assistant